Check out our latest work: personalized responses to chemotherapy and TKIs in pheochromocytomas/paragangliomas. Laying groundwork for assessing biochemical responses in PTOs @SciReports@KVotanopoulos@StevenDForsythe@WFIRMnews
https://t.co/IZ6VQQtrVT
Can we boost #HIPEC effectiveness with Bromelain?
Exciting new research from #WFORCE group, reveals its dual action as a mucolytic and cytotoxic agent, against appendiceal cancer organoids.#cancerresearch#innovation
Dive in the study here: https://t.co/A5HSBKNb4x
Had an opportunity to partner with @BehindTheKnife to record a podcast on LCBDE (out today!) with supplemental video tutorial series that can be found here: https://t.co/eazdovSiD2
We’ve worked hard on this content! Let us know what you think!
#LCBDE#MedEd#surgery#CBDstones
Maggie Bosley received a #SAGES2023 Recognition of Excellence Coin from Dana Telem. Excellence and dedication to SAGES and the dissemination of common bile duct evaluation and exploration. Thank you for helping lead the way AND continuing the incredible legacy of George Berci.
Congratulations to the 2023 @acpmpresearch Travel Award winners! 10 recipients received travel awards through the generosity of ACPMP. #ACT2023@AnnaPolyak2
#MerkelCellCarcinoma (MCC) is a rare #Cancer that is hard to research due to a lack of appropriate tissue models. However, a recent study has shown that #Organoids could be the answer to this tricky problem💪
Find out how in @Nature: https://t.co/fPY0SJbNis
#OrganoidPower
Strong showing at the NC/SC ACS Chapter meeting Cancer papers session in Myrtle Beach. Drew Erali, resident, and Ian Solsky, fellow, received first and third place for their research presentations, respectively. @WakeSurgonc@WakeCancer@NCSurgeons@WakeSurgEd
I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids as a platform for immunotherapy testing in appendiceal cancer, a rare but devastating disease. Thank you @KVotanopoulos@RAEraliMD
https://t.co/LvunYXDQDq
Our researchers were recently awarded a $2.5M grant from @theNCI to fund personalized medicine research for aggressive abdominal cancers at the Wake Forest Organoid Research Center, a joint effort between @WFIRMnews and @WakeCancer. Read more. https://t.co/clUKYIW70T